ProtonDx: Accurate, Rapid and Lab-Free Detection of SARS-CoV-2 and Other Respiratory Pathogens [Society News]

ProtonDx will provide a response to the COVID-19 pandemic by bringing nucleic-acid based molecular diagnostics palm of your hand. It support deployment Lacewing technology, which achieves accurate, rapid, handheld and low cost detection SARS-CoV-2 other respiratory infections. Results are synchronized electronic health records geotagged for real-time surveillance disease progression. The device was designed use at point need, in places such as pharmacies, schools workplaces. Its unique approach combines standard semiconductor advanced biology 3D printed microfluidics match performance bench-based instrument. Clinical trials currently progress Imperial NHS Trust, London, UK lead regulatory approvals commercialization next few months.